Biotech

All Articles

Lykos will definitely ask FDA to reconsider its own choice adhering to rejection of MDMA treatment for trauma

.Complying with an inadequate presenting for Lykos Therapeutics' MDMA candidate for post-traumatic s...

AN 2 fifty percents headcount, quits period 3 test after records disappoint

.AN2 Rehabs is rethinking its service in action to poor midphase records, promising to give up half ...

Merck pays $700M for bispecific, snooping autoimmune position and odds to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 thousand in advance to challenge Amgen in a blood cancer...

Gilead pays for J&ampJ $320M to exit licensing bargain for seladelpar

.With Gilead Sciences on the verge of an FDA selection for its own liver illness medicine seladelpar...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks may find the companies putting together tents at basecamp respo...

Entero laying off staff, abandoning workplace and pausing R&ampD

.Bed mattress Liquidators has transformed Entero Therapeutics white as a piece. The collector purcha...

Exelixis falls ADC after choosing it is actually no suit for Tivdak

.Exelixis is actually surrendering on its cells element (TF)- targeting antibody-drug conjugate afte...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three full weeks after Roche's Genentech device bowed out an SHP2 inhibitor pact, Relay Rehab has a...

Stoke's Dravet disorder med released of predisposed scientific grip

.Stoke Therapies' Dravet syndrome drug has been devoid of a predisposed grip, getting rid of the met...

Fierce Biotech's Gabrielle Masson offers Brutal 15 at NYSE

.Brutal Biotech Affiliate Publisher Gabrielle Masson presented the 2024 course of Strong 15 winners ...